Over-the-counter Dispensing: Widening Access to Inhaled Corticosteroid/Formoterol Reliever Therapy
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Respiratory and Critical Care Medicine"
DOI: 10.1164/rccm.202212-2297ed
Abstract: The limited availability of low-dose inhaled corticosteroid (ICS)/formoterol reliever therapy in many countries is an issue of international concern. As recommended by the GINA (Global Initiative for Asthma) strategy, ICS/formoterol is preferred to short-acting b2… read more here.
Keywords: ics formoterol; reliever therapy; reliever; formoterol reliever ... See more keywords
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2020.5237
Abstract: Introduction: In asthma, maintenance and reliever therapy (MART) with inhaled corticosteroid (ICS)/formoterol reduces exacerbations compared to fixed-dose therapy with ICS/long-acting β2-agonist. No studies have investigated MART in patients with chronic obstructive pulmonary disease (COPD). Methods:… read more here.
Keywords: maintenance reliever; therapy; dose therapy; reliever therapy ... See more keywords